Brunei vs IDA & IBRD total: Cause of death, by non-communicable diseases
Brunei
80.8%
in 2021
IDA & IBRD total
60.0%
in 2021
Brunei rank
25th
IDA & IBRD total rank
22nd
Cause of death, by non-communicable diseases over time
- Brunei
- IDA & IBRD total
How they compare
Brunei currently reports 80.8% against 60.0% in IDA & IBRD total, a difference of 20.8%.
That makes Brunei's figure about 1.3 times IDA & IBRD total's.
Across all 6 years both countries report, Brunei has been ahead every year.
Brunei ranks 25th and IDA & IBRD total ranks 22nd of 185 countries.
Brunei has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei | IDA & IBRD total | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 78.7% | 53.8% | 24.9% | Brunei |
| 2010s | 81.5% | 67.0% | 14.5% | Brunei |
| 2020s | 81.9% | 63.0% | 18.9% | Brunei |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, Brunei or IDA & IBRD total?
- Brunei, at 80.8% against 60.0% in IDA & IBRD total as of 2021.
- What is the difference in cause of death, by non-communicable diseases between Brunei and IDA & IBRD total?
- 20.8%, with Brunei ahead.
- How many years of comparable data are there for Brunei and IDA & IBRD total?
- 6 years are reported by both, from 2000 to 2021.
- How do Brunei and IDA & IBRD total rank globally for cause of death, by non-communicable diseases?
- Brunei ranks 25th and IDA & IBRD total ranks 22nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases (% of total). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Cause of death refers to the share of all deaths for all ages by underlying causes. Non-communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.